Evaluation of Novel Biomarkers for Response to Treatment and Outcome in Dogs with Immune-Mediated Haemolytic Anaemia

People: Barbara Glanemann, James Swann, Balazs Szladovits, Brian Catchpole, Ruby Chang, Sivert Nerhagen

We are conducting a prospective study to try to identify novel markers of disease activity that can predict response to treatment and likelihood of developing side effects related to immunosuppressive medications.